REFERENCES
- Gutman, A. B. and Gutman, E. B.: An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostatic gland. J Clin Invest 17: 473, 1938.
- Schwartz, M. K., Greenberg, E. and Bodansky, O.: Comparative values of phosphatases and other serum enzymes in following patients with prostatic carcinoma. Cancer 16: 583, 1963.
- Hock, E. and Tessier, R. N.: Elevation of serum acid phosphatase following prostatic massage. J Urol 62: 488, 1949.
- Woodard, H. Q.: Clinical significance of serum acid phosphatase. Amer J Med 27: 902, 1959.
- Delory, G. E., Sweetser, T. H., Jr. and White, T. A.: The use of formalin and alcohol in the estimation of prostatic phosphatase. J Urol 66: 724, 1951.
- Abul-Fadl, M. A. M. and King, E. J.: Properties of the acid phosphatases of erythrocytes and of the human prostate gland. Biochem J 45: 51, 1949
- Bonner, C. D., Homburger, F., Smithy, G. B. and Borges, P. R. F.: “Prostatic” serum acid phosphatase in cancer of the prostate. JAMA 164: 1070, 1947.
- Fishman, W. H., Bonner, C. D. and Homburger, F.: Serum “prostatic” acid phosphatase and cancer of the prostate. New Eng J Med 255: 925, 1956.
- Hill, J. H.: Prostatic serum acid phosphatase in patients with localized prostatic cancer. Amer J Clin Path 26: 120–130, 1956.
- Langley, J. R.: The deceptive acid phosphatases. Calif Med 103: 343, 1965.
- Marshall, G. and Amador, E.: Diagnostic usefulness of serum acid β-glycerophosphatase activities in prostatic disease. Amer J Clin Path 51: 551, 1969.
- Amador, E., Price, J. W. and Marshall, G.: Serum acid α-naphthyl phosphatase activity. Amer J Clin Path 51: 202, 1969.
- Baker, R. and Govan, D.: The effect of hormonal therapy of prostatic cancer on serum aldolase. Cancer Res 13: 141, 1953.
- Amador, E., Wacker, W. E. C. and Harrison, J. H.: Urinary LDH activity in neoplastic and inflammatory diseases of the urinary tract. Amer J Clin Path 49: 271, 1968.
- Denis, L. J. and Prout, G. R., Jr.: Lactic dehydrogenase in prostatic cancer. Invest Urol 1: 101, 1963.